← All organizations

Eckert & Ziegler Radiopharma GmbH

Academic/Hospital

Also known as: Eckert & Ziegler Radiopharma GmbH | PentixaPharm GmbH

Highest phase reached

Phase 3

First clinical trial

Oct 5, 2022

Last known activity

Mar 21, 2024

Timeline

2020s

  1. Apr 16, 2021

    Pentixapharm AG— Acquired

Drugs by trial phase (3 distinct, 5 trials)

Phase 3 (1 own, 2 via acquisition)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (2)

Details

Last known activity
Mar 21, 2024